Steering Committee Meeting - 07/2009
From LipidomicsWiki
(Difference between revisions)
m |
|||
| Line 178: | Line 178: | ||
== Tuesday 13th of July 2009<br> == | == Tuesday 13th of July 2009<br> == | ||
| - | {| class=" | + | {| class="wikitable" |
|- | |- | ||
| <br> | | <br> | ||
Revision as of 10:46, 13 May 2009
Contents |
Date
1st Annual Steering Committee Meeting Regensburg, 13th - 14th July 2009
Venue
University Hospital Regensburg Franz-Josef-Strauss-Allee 11D-93053 RegensburgGermany
Phone: +49-941-944-6203
Agenda
Monday, 13th of July 2009
| Time | Monday, 13.07.2009 | |
|---|---|---|
| 08:30 - 08:40 | Introduction / Welcome (Prof. G. Schmitz, Regensburg) | |
| Presentations of the LipidomicNet Scientific Advisory Committee and Audit and Ethics Committee | ||
| 08:40 - 08:50 | Scientific Advisory Committee Prof. M. Wenk | |
| 08:50 - 09:00 | Scientific Advisory Committee Prof. E. Dennis | |
| 09:00 - 09:10 | Scientific Advisory Committee Prof. D. Brasaemle | |
| 09:10 - 09:20 | Audit and Ethics Committee N. N. (no confirmation received) | |
| 09:20 - 09:30 | Audit and Ethics Committee N. N. (no confirmation received) | |
| Work package and deliverable-orientated presentations | ||
| | WP 1 (Chair: Prof. G. Schmitz) | Scientific management |
| | WP 2, together with TF I - IV (Chair: Prof. C. Thiele) | Enabling technologies
|
| | Dr. M. Grandl (P01) | High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages |
| | Dr. G. Liebisch (P01) | Analysis of glycerophosphoplipid species |
| | M. Scherer (P01) | Analysis of sphingolipid species |
| | Dr. J. Hansen (P01) | Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array |
| | WP 3, together with TF V (Chair: Prof. C. Wolfrum) | Mouse models of liver and adipose lipid droplet processing |
| | N. N. N. N: | Rühl-Kooperation-Liver/LXR ATP10D and liver |
| | WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam) | Dysregulation of liver and adipose lipid droplet processing in human diseases
|
| | Dr. V. Tarabin (P01)
| Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation |
| | Dr. J. Ecker (P01) | Metabolic changes of lipid metabolism during adipocyte differentiation |
| | Dr. C. Hellerbrand / Dr. T. Weiss (P01)
| Influence of palmitate and ω3/ ω6-fatty acids on human liver cells |
| | Coffee Break | |
| | WP 5 (Chair: Prof. Schmitz) | Lipid droplets and lipid bodies in human macrophages and leukocytes
|
| | K. Rübsaamen (born Leidl) (P01) | Lipidomic analysis of monocytes and granulocytes |
| | Dr. A. Sigrüner (P01) | Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes |
| | Dr. J. Ecker (P01) | The role of SREBP-1c mediated induction of lipid metabolism for macrophage development |
| | Dr. Margot Grandl (P01) | Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment. |
| | Dr. K. Leuthäuser-Jaschinski (P01) | Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages |
| | Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01) | N/N |
| | N/N | Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics |
| | WP 6 (Chair: Prof. Sandhoff) | Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies |
| | Lunch | |
| | WP 7, together with TF VIII (Chair: Dr. L. Martens) | Bioinformatics |
| | Dr. P. Ugocsai (P01) | Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study |
| | J. Koopmann (P01) | Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study |
| | WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć) | Dissemination and training
|
| | Coffee Break | |
Tuesday 13th of July 2009
| | Tuesday, 14.07.2009 | |
| | Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee | |
| | Scientific Advisory Committee | |
| | Scientific Advisory Committee | |
| | Scientific Advisory Committee | |
| | Audit and Ethics Committee | |
| | Audit and Ethics Committee | |
| | Coffee break | |
| 13:00 | End of meeting | |
